Showing results (1111-1120 of 6,501) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|January 23, 2020
Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinomaXiaofeng Li, Yufan Zhang, Wenchao Ma, et al.Cancer Immunology, Immunotherapy : CII|December 15, 2018
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma modelDiana Llopiz, Marta Ruiz, Lorea Villanueva, et al.Cancer Immunology, Immunotherapy : CII|August 22, 2017
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)Sridharan Gururangan, Elizabeth Reap, Robert Schmittling, et al.Cancer Immunology, Immunotherapy : CII|March 24, 2018
Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccinationKazuyoshi Takeda, Kazutaka Kitaura, Ryuji Suzuki, et al.Cancer Immunology, Immunotherapy : CII|November 3, 2019
Immunomodulation by Schwann cells in diseaseSophia H Zhang, Galina V Shurin, Hasan Khosravi, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Modulation of the immune response to tumors by a novel synthetic compound, N-[4-[(4-fluorophenyl)sulfonyl]phenyl] acetamide (CL 259,763)B S Wang, V Ruszala-Mallon, R E Wallace, et al.Cancer Immunology, Immunotherapy : CII|January 5, 2018
Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cellsTina Nham, Sophie M Poznanski, Isabella Y Fan, et al.Cancer Immunology, Immunotherapy : CII|January 5, 2018
Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimerasIsabelle Dierckx de Casterlé, Sabine Fevery, Omer Rutgeerts, et al.Cancer Immunology, Immunotherapy : CII|January 10, 2018
Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapyXiaopeng Yuan, Mingjuan Yang, Xiang Chen, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1985
Selective toxicity of neocarzinostatin-monoclonal antibody conjugates to the antigen-bearing human melanoma cell line in vitroG Lüders, W Köhnlein, C Sorg, et al.Pageof 651